Loading
Advances in Oncology and Radiotherapy · Journal article
Frontiers in Oncology · September 4, 2026
A consensus or society position rather than new primary data.
This is a policy analysis and expert review that frames cancer-system deterioration in Palestine as arising from the interaction of prolonged occupation, armed conflict, restricted mobility, governance failure, and fiscal constraint. It does not report original empirical findings or comparative outcome data, but rather synthesizes contextual factors and proposes a framework for understanding oncology access and a set of practical reconstruction actions.
Policy and Practice Review. Cancer care systems in Palestine (Gaza Strip and West Bank), with historical and regional comparators (Japan, West Germany, East Timor, Israel, neighboring referral systems).. Palestine (Gaza Strip and West Bank); comparisons with Japan, West Germany, East Timor, Israel, and regional centers..
Absence of radiotherapy in the Gaza Strip Late and limited radiotherapy introduction in the West Bank Dependence on permit-mediated referrals to East Jerusalem and regional centers
No quantitative outcome data (mortality, survival, treatment delays, or patient numbers) are reported.
Clinicians and health-system planners should use this framework to understand how occupation and conflict disrupt cancer care continuity and to prioritize the proposed protective actions—protected referral corridors, diagnostic recovery, medicine protection, radiotherapy reconstruction, and rights-based monitoring—when advocating for or planning cancer services in fragile and conflict-affected settings.
A policy and practice review advancing a framework for understanding cancer-system deterioration under occupation and conflict, with proposed practical actions for health-system strengthening—not a clinical trial or empirical study generating original evidence.
As stated by the source record.
Clinicians and health-system planners should use this framework to understand how occupation and conflict disrupt cancer care continuity and to prioritize the proposed protective actions—protected referral corridors, diagnostic recovery, medicine protection, radiotherapy reconstruction, and rights-based monitoring—when advocating for or planning cancer services in fragile and conflict-affected settings.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Cancer care in fragile and conflict-affected settings is increasingly recognized as a challenge for global oncology. This Policy and Practice Review examines cancer care in Palestine as a case study of how prolonged occupation, armed conflict, restricted mobility, fragmented governance, fiscal constraint, and limited health sovereignty interact to shape early diagnosis, treatment continuity, radiotherapy access, systemic therapy, referral pathways, and patients’ rights. Rather than treating occupation as a uniform determinant of health outcomes, the manuscript advances a more defensible framework: cancer systems deteriorate where political control, poor governance, conflict, and fiscal crisis interrupt institutional continuity; conversely, health systems consolidate after conflict or occupation only when reconstruction is linked to restored civilian authority, accountable institutions, protected movement, and sustained infrastructure investment. Palestine is analyzed alongside brief historical and regional comparators, including Japan, West Germany, East Timor, Israel, and neighboring referral systems. The review highlights the absence of radiotherapy in the Gaza Strip, the late and still limited introduction of radiotherapy in the West Bank, dependence on permit-mediated referrals to East Jerusalem and regional centers, the collapse of oncology access after October 2023, and recent medicine shortages affecting cancer treatment in both the Gaza Strip and the West Bank. It connects oncology disruption with patients’ rights, structural violence, ecologies of war, therapeutic geographies, and health-system governance under occupation. Finally, it proposes practical actions: protected oncology referral corridors, urgent diagnostic recovery, chemotherapy and essential-medicine protection, companion-supported medical evacuation, radiotherapy reconstruction, audited cancer financing, regional mutual-aid agreements, digital oncology records, workforce support, and rights-based monitoring of delays, denials, and preventable deaths.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.